DHA/ARA Term Infant Formula Negative Findings Cast Doubt On Launches
This article was originally published in The Tan Sheet
Executive Summary
Negative research results relating to DHA/ARA supplementation of term infant formulas could delay the U.S. launch of formulas containing the fatty acids.
You may also be interested in...
Enfamil LIPIL Future “Unique Blend” Claims Should Be Clarified, NAD Says
Mead Johnson should clarify future marketing claims forEnfamil LIPIL to avoid the implication it is the only infant formula on the market fortified with fatty acids DHA and ARA, the National Advertising Division of the Council of Better Business Bureaus says in a recent decision
Enfamil LIPIL Future “Unique Blend” Claims Should Be Clarified, NAD Says
Mead Johnson should clarify future marketing claims forEnfamil LIPIL to avoid the implication it is the only infant formula on the market fortified with fatty acids DHA and ARA, the National Advertising Division of the Council of Better Business Bureaus says in a recent decision
Enfamil LIPIL Future “Unique Blend” Claims Should Be Clarified, NAD Says
Mead Johnson should clarify future marketing claims forEnfamil LIPIL to avoid the implication it is the only infant formula on the market fortified with fatty acids DHA and ARA, the National Advertising Division of the Council of Better Business Bureaus says in a recent decision